S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]
-
* Corresponding author: Wadie I Najm winajm@uci.edu
BMC Musculoskeletal Disorders 2004, 5:6 doi:10.1186/1471-2474-5-6
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 22 Jul 2003 | |
| Reviewer's Report | Betsy Singh | 05 Aug 2003 | |
| Reviewer's Report | David Scott | 14 Aug 2003 | |
| Reviewer's Report | Teodoro Bottiglieri | 05 Sep 2003 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 17 Sep 2003 |
| Resubmission - Version 3 | Manuscript | Author's comment | 08 Jan 2004 |
| Reviewer's Report | Teodoro Bottiglieri | 29 Jan 2004 | |
| Published | 26 Feb 2004 |